National Quality Forum #: None
Numerator: Number of patients with a diagnosis of HIV who ever received a pneumococcal vaccine2
Denominator: Number of patients with HIV who had a medical visit with a provider with prescribing privileges3 at least once in the measurement year
Patient Exclusions: Patients with CD4 counts <200 cells/mm3 within the measurement year
- Does the patient have a diagnosis of HIV? (Y/N)
- If yes, is there documentation in the chart that the patients ever received the pneumococcal vaccine? (Y/N)
National goals, target, or benchmarks for comparison
The HIV Quality Measures (HIVQM) Module is a tool within the Ryan White HIV/AIDS Services Report portal. It allows recipients to enter aggregate data specific to HRSA HAB Performance Measures. The HIVQM Module allows recipients to conduct point-in-time benchmarking across Ryan White HIV/AIDS Programs that use the module.
Department of Health and Human Services Clinical Practice Guidelines
Pneumococcal vaccination is recommended for "all people with HIV regardless of CD4 count. Patients with CD4 counts >200 cells/mm3 should receive a dose of PPSV23 at least 8 weeks later (AI). While individuals with HIV with CD4 counts <200 cells/mm3 can also be offered PPSV23 at least 8 weeks after receiving PCV15 (CIII) (such as if there are concerns with retention in care), PPSV23 should preferably be deferred until after an individual's CD4 count increases to >200 cells/mm3 while on ART (BIII)."4
Use in other federal programs
The Centers for Medicare and Medicaid Services, Medicare and Medicaid EHR Incentive Program for Eligible Professionals, eCQM Library, includes a Pneumococcal Vaccination Status for Older Adults measure. However, this measure includes only adults 66 years of age and older. See Measure CMS127v10.
1 "Clients" includes all clients aged 13 years and older.
2 Evidence of vaccination could include personal, school, physician, or immunization records or registries.
3 A "provider with prescribing privileges" is a health care professional certified in his/her jurisdiction to prescribe medications.
4 Panel on Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: Recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America (PDF - 5 MB). Department of Health and Human Services. Available online. Accessed August 2023. G-16.